The cardinal immunophenotypic characteristic of DLBCL encompasses expression of B-lineage markers, predominantly CD20 and PAX5, with variable morphological heterogeneity (Figures 4C, D). Here, PAX5 is linked to diffuse large B-cell lymphoma.